IL125803A0 - Dosage form of ibuprofen - Google Patents

Dosage form of ibuprofen

Info

Publication number
IL125803A0
IL125803A0 IL12580397A IL12580397A IL125803A0 IL 125803 A0 IL125803 A0 IL 125803A0 IL 12580397 A IL12580397 A IL 12580397A IL 12580397 A IL12580397 A IL 12580397A IL 125803 A0 IL125803 A0 IL 125803A0
Authority
IL
Israel
Prior art keywords
dosage form
ibuprofen
fever
bicarbonate
pain
Prior art date
Application number
IL12580397A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of IL125803A0 publication Critical patent/IL125803A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12580397A 1996-02-21 1997-02-19 Dosage form of ibuprofen IL125803A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition
PCT/EP1997/000841 WO1997030699A2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Publications (1)

Publication Number Publication Date
IL125803A0 true IL125803A0 (en) 1999-04-11

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12580397A IL125803A0 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Country Status (25)

Country Link
US (1) US20020034540A1 (OSRAM)
EP (1) EP0881899B1 (OSRAM)
JP (2) JP2000507922A (OSRAM)
KR (1) KR19990087084A (OSRAM)
CN (1) CN1215989A (OSRAM)
AT (1) ATE273696T1 (OSRAM)
AU (1) AU722991B2 (OSRAM)
BG (1) BG64165B1 (OSRAM)
CA (1) CA2246344C (OSRAM)
CZ (1) CZ298371B6 (OSRAM)
DE (1) DE69730314T2 (OSRAM)
DK (1) DK0881899T3 (OSRAM)
ES (1) ES2227670T3 (OSRAM)
GB (1) GB9603699D0 (OSRAM)
HU (1) HUP9901454A3 (OSRAM)
IL (1) IL125803A0 (OSRAM)
NO (1) NO983825L (OSRAM)
NZ (1) NZ331416A (OSRAM)
PL (1) PL187383B1 (OSRAM)
PT (1) PT881899E (OSRAM)
RU (1) RU2182000C2 (OSRAM)
SK (1) SK285032B6 (OSRAM)
UA (1) UA55407C2 (OSRAM)
WO (1) WO1997030699A2 (OSRAM)
ZA (1) ZA971446B (OSRAM)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
US20030008003A1 (en) * 2001-04-10 2003-01-09 Fahkreddin Jamali Compositions for enhanced absorption of NSAIDs
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
US9492388B2 (en) * 2002-12-20 2016-11-15 St. James Associates Llc/Faber Research Series Coated particles for sustained-release pharmaceutical administration
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP3216445A1 (en) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Oral therapeutic compound delivery system
CA2572359C (en) * 2004-06-29 2010-08-03 Nycomed Danmark Aps Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
WO2006016125A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising a nsaid and a sugar alcohol made by melt extrusion
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
ZA200702694B (en) * 2004-09-30 2008-07-30 Scolr Pharma Inc Modified release ibuprofen dosage form
CA2589079A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
EP1850834B1 (de) * 2005-02-09 2014-08-20 Boehringer Ingelheim International GmbH Filmtabletten enthaltend ibuprofen-lysinat
CA2602392A1 (en) 2005-03-22 2006-09-28 Losan Pharma Gmbh Solubilized ibuprofen
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
CA2622704A1 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20070521A7 (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EP2291233B1 (en) * 2008-05-09 2019-09-04 Atacama Labs Oy Method for dry granulation
MX337488B (es) 2008-07-21 2016-03-08 Si Group Inc Granulos con alto contenido de ibuprofeno sodico, su preparacion y su uso en preparar formas de dosificacion solidas no efervescentes.
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
CA2764740C (en) * 2009-06-22 2015-09-01 Wyeth Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
MX371068B (es) 2014-07-02 2020-01-15 ObsEva SA ((3z,5s)-5-(hidroximetil)-1-[(2'-metil-1,1'-bifenil-4-il)carbonil ]pirrolidin-3-ona o-metiloxima cristalina y métodos de uso de la misma.
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
AU8320387A (en) * 1986-10-22 1988-05-25 Upjohn Company, The Treatment of gingivitis with ibuprofen or flurbiprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
SK279279B6 (sk) * 1991-05-13 1998-09-09 The Boots Company Plc S(-)-nátrium-2-(4-izobutylfenyl)propionát-dihydrát
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
ES2134796T3 (es) * 1992-12-01 1999-10-16 Spirig Ag Pharmazeutische Prap Composiciones farmaceuticas que contienen s(+)-ibuprofeno.

Also Published As

Publication number Publication date
ES2227670T3 (es) 2005-04-01
PT881899E (pt) 2004-12-31
SK114298A3 (en) 1999-01-11
CA2246344A1 (en) 1997-08-28
CN1215989A (zh) 1999-05-05
DE69730314D1 (de) 2004-09-23
WO1997030699A3 (en) 1997-10-09
AU722991B2 (en) 2000-08-17
EP0881899B1 (en) 2004-08-18
NZ331416A (en) 2000-02-28
PL187383B1 (pl) 2004-06-30
DK0881899T3 (da) 2004-12-20
ATE273696T1 (de) 2004-09-15
NO983825L (no) 1998-10-20
UA55407C2 (uk) 2003-04-15
BG102744A (bg) 1999-05-31
HUP9901454A3 (en) 2001-04-28
AU1793797A (en) 1997-09-10
ZA971446B (en) 1997-11-25
BG64165B1 (bg) 2004-03-31
EP0881899A2 (en) 1998-12-09
CA2246344C (en) 2009-01-20
US20020034540A1 (en) 2002-03-21
KR19990087084A (ko) 1999-12-15
RU2182000C2 (ru) 2002-05-10
HUP9901454A2 (hu) 1999-08-30
SK285032B6 (sk) 2006-05-04
CZ261798A3 (cs) 1998-11-11
PL328465A1 (en) 1999-02-01
JP2000507922A (ja) 2000-06-27
CZ298371B6 (cs) 2007-09-12
NO983825D0 (no) 1998-08-20
GB9603699D0 (en) 1996-04-17
DE69730314T2 (de) 2005-08-18
WO1997030699A2 (en) 1997-08-28
JP2009073847A (ja) 2009-04-09

Similar Documents

Publication Publication Date Title
IL125803A0 (en) Dosage form of ibuprofen
US5782971B1 (en) Calcium phosphate cements comprising amorophous calcium phosphate
ZA899372B (en) Hemostatic collagen paste composition
CA2265766A1 (en) Rapidly disintegrating pellets
ES2046083A1 (es) Procedimiento para preparar composiciones de liberacion prolongada.
CA2284663A1 (en) Rapidly dissolving robust dosage form
ES2033196A1 (es) Granulos diospersables de productos fungicidas.
CA2253797A1 (en) Luminous or fluorescent artificial stone composition
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
IL112518A0 (en) Thyroid hormone fast dispersing pharmaceutical composition
ZA949309B (en) Composition for the production of therapeutic products in vivo
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ES2188774T3 (es) Composiciones cosmeticas en polvo que tienen un poder cubriente mejorado.
DE3170764D1 (en) Fast disaggregating pharmaceutical tablet
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
MY109531A (en) Effervescent antacid
MY110014A (en) Psyllium-containing products.
CA2210321A1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
EP0237241A3 (en) Calcium supplement compressed tablets
EP0367056A3 (en) A granulating composition and method
GR3036470T3 (en) Process for preparing a clodronate preparation
ES2059260A1 (es) Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
AP2000001914A0 (en) Paroxetine compositions.
HRP931091B1 (en) Metallothermic reaction mixture
JPS5655305A (en) Material for repairing dental cavity